UK becomes first to authorize Merck and Ridgeback Biotherapeutics’ antiviral molnupiravir to treat mild-to-moderate Covid-19
It is the world's first oral antiviral to be authorized anywhere for the treatment of Covid-19. The drug comes in ...
It is the world's first oral antiviral to be authorized anywhere for the treatment of Covid-19. The drug comes in ...
© 2025 Web Sense Services - Web Sense Servicesby Web Sense Services.
© 2025 Web Sense Services - Web Sense Servicesby Web Sense Services.